FSU researcher's 'mutant' proteins could lead to new treatment for heart disease

Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem.

Michael Blaber, a professor in the department of biomedical sciences, is researching mutant forms of a human protein that have been shown to help the human body grow new blood vessels to restore blood flow in damaged areas of the heart.

Working with a $264,000, three-year grant from the American Heart Association, Blaber hopes to provide data that will enable the use of the mutant proteins in new treatment methods previously unavailable for patients with advanced “no option’’ heart disease.

“This research offers the potential to treat people who currently are being sent home to die,’’ Blaber said. “We’ve tested a group of mutants in the laboratory with unusual properties of increased stability and activities -- good properties. In some cases it was unexpected, but the results are very promising.’’

Obstructed blood vessels and clogged or blocked arteries typically are treated through angioplasty, the mechanical widening of a vessel, or bypass surgery. Some patients, however, have numerous small blockages that cannot be treated through traditional approaches. In most cases, they are sent home with a predicted life expectancy that, no matter how it’s phrased, sounds like a death sentence.

A new approach to the problem called therapeutic coronary angiogenesis is creating hope through the injection of human fibroblast growth factor protein into affected areas. Improvements with the procedure may arise from the use of mutant forms with increased stability.

Blaber and his research team are creating artificial “mutant’’ proteins in their College of Medicine laboratory that mimic the human proteins used in angiogenic therapy, and with enhanced stability properties. So far, the mutant proteins engineered at the College of Medicine have exhibited potency in stimulating cell growth while simultaneously maintaining greater stability under conditions common to angiogenic therapy.

The work has enormous potential commercial applications and already has drawn the attention of private companies interested in the results Blaber’s lab has achieved and the intellectual properties his studies are generating.

Source: Florida State University

Related stories:

Newly defined signaling pathway could mean better biofuel sources
A newly defined biochemical pathway in plants may provide the scientific tools to design plants that will yield larger quantities of alternative transportation fuels than currently can be produced, according to Purdue University researchers.
Novel molecules can boost vaccine potency
Two novel proteins studied by a University at Buffalo professor of microbiology and immunology appear to have the potential to enhance the production of antibodies against a multitude of infectious agents.
Biologists use computers to study bacterial cell division
A group of computational biologists at Virginia Tech have created a mathematical model of the process that regulates cell division in a common bacterium, confirming hypotheses, providing new insights, identifying gaps in what is understood so far, and demonstrating the role of computation in biology.
Why the Switch Stays On: Scientists Discover Reasons Behind Cancerous Cellular Interactions
Cellular processes, such as when to multiply, are often regulated by switches that control the frequency and timing of interactions between proteins. North Carolina State University scientists have discovered the way in which a specific protein-protein interaction prevents the cell from turning one of its switches off, leading to uncontrolled cell proliferation – one of the hallmarks of cancer.
Quantum Dots Reach Clinical Lab
Bioconjugated quantum dots – luminescent nanoparticles linked to biological molecules – have shown great promise as tools for disease diagnosis and treatment, but their medical use has been limited by the lack of specific instructions for clinicians. Now, new clinical protocols detailing how to prepare, process and quantify these tiny particles will arm laboratory physicians with the information they need to track biomarkers in cells and tissues.
Discovery Raises Questions About Some Therapies Designed to Treat Half of all Human Cancers
Biologists at the University of California, San Diego have uncovered a new way by which common mutants of a critical human tumor-suppressing gene can promote tumor progression, a finding which may explain why some cancer treatments targeting human cancers with these mutants have proven ineffective.
Genetic hearing loss may be reversible without gene therapy
A large proportion of genetically caused deafness in humans may be reversible by compensating for a missing protein, based on discoveries in mice.
Scientists Reveal a Virus’ Secret Weapon
It takes more than just breaking and entering for a virus to successfully invade a cell. Getting to the cell’s center—where the host cell’s machinery will be co-opted to make more virus—requires navigating obstacles such as membranes and avoiding being recognized and kicked out by the host.

News discussion:

Medicine & Health news